26 related articles for article (PubMed ID: 12019370)
1. The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.
Nutt JE; Razak AR; O'Toole K; Black F; Quinn AE; Calvert AH; Plummer ER; Lunec J
Br J Cancer; 2010 Feb; 102(3):553-60. PubMed ID: 20051956
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
3. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
4. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M
Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
7. Despite some expression of folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated.
Khokhar NZ; Lam AF; Rusch VW; Sirotnak FM
J Thorac Cardiovasc Surg; 2002 May; 123(5):862-8. PubMed ID: 12019370
[TBL] [Abstract][Full Text] [Related]
8. Membrane transport of folates.
Matherly LH; Goldman DI
Vitam Horm; 2003; 66():403-56. PubMed ID: 12852262
[TBL] [Abstract][Full Text] [Related]
9. Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell.
Bosson G
Br J Biomed Sci; 2003; 60(2):117-29. PubMed ID: 12866924
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate transport and resistance.
Moscow JA
Leuk Lymphoma; 1998 Jul; 30(3-4):215-24. PubMed ID: 9713954
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies targeting proteins that regulate folate and reduced folate transport.
Trippett TM; Bertino JR
J Chemother; 1999 Feb; 11(1):3-10. PubMed ID: 10078775
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular biology of the human reduced folate carrier.
Matherly LH
Prog Nucleic Acid Res Mol Biol; 2001; 67():131-62. PubMed ID: 11525381
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]